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global economic and political system?
Tsai nimbly handled these rather chal-
lenging questions by pointing out the
need for a proactive attitude to play a
positive role in the government’s con-
sensus policy on all socio-economic
groups, rather than just pharmaceuti-
cal companies and researchers. If aca-
demics are going to say something
about genomics, argued Tsai, they
might as well use their position and
skills to voice the views of the socio-
genetically marginal, and articulate
them with an eye on socio-economic
improvement for the weak. 
Margaret Sleeboom discussed this
issue regarding genetic sampling in
Mainland China and in Taiwan. Her
comparison of political and socio-eco-
nomic interest groups involved in pub-
lic discussion on genetic sampling and
the definitions of targeted groups in
both states showed that their different
cultural and political composition leads
to different research regulation and
practices. This was demonstrated by the
clearly distinguishable ways in which
scientists in these two states define
their research population, collect their
genetic samples, and conduct their
research. Thus, different political and
cultural views on the ‘ethnic’ nature of
the Chinese and Taiwanese populations
not only affected the treatment of sam-
pling populations, which often occupy
weak socio-economic positions, but
also the scientific outcome of genetic
research. 
The relevance of the attitude of intel-
lectuals towards the application of new
genetic technologies, such as genetic
screening, was seconded by NIE Jing-
bao (Otago University, New Zealand).
Nie characterized the Chinese birth-
control programme as ‘probably
unprecedented and unrivalled regard-
ing its massive scale and profound
impact’. In its twofold aim to control
the ‘quantity of the population’ and to
improve the ‘quality of the population’,
the latter has received increasing
emphasis in the 1990s. The ideological
underpinning for this socio-genetic
engineering programme, argues Nie,
draws on various forms of social Dar-
winism, biological determinism, sta-
tism, scientism, utopianism, and reduc-
tionism in the sense that it addresses
complex social problems in which
bureaucracy, controlled by scientists
and technicians, plays a considerable
role.
Genetic citizenship?
Analogous to ‘queer citizenship’, in
the United States a coalition between
patient families, politicians, and scien-
tists has been forged, leading to politi-
cal activism for ‘genetic citizenship’ –
defending the rights of the genetically
disadvantaged – and against genetic
discrimination by insurance companies
and employers. Kaori MUTO (Shinshu
University, Japan) discussed the form
that genetic citizenship will take in Asia
at the dawn of the ‘era of molecular epi-
demiology’: the latter attempts to
explain social behaviour through the
biological make-up of people. Muto
illustrated this by her study on Japan-
ese families with Huntington’s Disease,
ten years after the identification of the
responsible gene. For, also in Asia,
molecular epidemiology leads to new
forms of health promotion, preventive
medicine, and increasingly ‘individu-
alized’ therapies.
Drawing on interviews with clini-
cians, excerpts from clinic-based ethno-
graphic observations in India, and nar-
ratives of infertile couples from
differing social-economic backgrounds,
Aditya Bharadwaj (Cardiff University,
Wales) showed how couples are caught
between societal disapproval of infer-
tility and protracted, financially debili-
tating medical interventions. Their
reproductive agency often takes the
form of resisting (seemingly) unending
cycles of medical treatment, while, at
the same time, they demonstrate an
interest in pursuing such treatment so
as to alleviate intense familial and soci-
etal pressures.
Jyotsna Gupta (LUMC, Leiden) also
noticed that genetic diseases in the
reproductive field receive great atten-
tion. She weighed its benefits against
the money that could be allocated to the
genetic diagnoses of common diseases
such as of thalassaemia and sickle-cell
anaemia. More investment in the diag-
nosis of communicable diseases, such
as tuberculosis, would even prevent cer-
tain cases of infertility and sub-fertility
in both males and females. Nearly all
members of our panel agreed that the
‘organic intellectual’ may be failing to
give a voice to the narratives of the
socio-genetically marginal. Thus Gupta
asked rhetorically, ‘in whose interest is
a genetic horoscope if a vast Indian
majority strongly believes in an astro-
logical horoscope cast at a child’s birth?’
Disagreement remained, however, as
to whether researchers should have a
mediating role between the various
political and economic interest groups,
or try to take distance from the com-
promising field of genetic politics. <
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Few will dispute that new genetic technologies will become very useful in the prediction of
disease and diagnostics. Nonetheless, the health and position of some social groups and
individuals may be adversely affected when genetic information is applied in any social
context. The concept of socio-genetic marginalization draws attention to the practice of
relating the social to the (assumed) genetic make-up of people and brings out its
consequences. Certain groups and individuals may find themselves isolated as a
consequence of discrimination on the basis of genetic information, and suffer the
psychological burden of the knowledge, feelings of social inaptitude, and a sense of
financial uncertainty.
By Margaret  S leeboom
During our ICAS3 meeting weexplored the ways in which gov-
ernment/state policies affect the fate of
the socio-genetically marginal, and the
role that researchers play in the process
of developing and applying the fruits of
genomics. According to TSAI Dujian
(National Yang Ming University, Tai-
wan), consensus building can have a
mediating role in Taiwanese genomic
policy. So-called ‘organic intellectuals’
(Gramsci) ought to provide a challenge
to the one-dimensional logic of techno-
logical progress by developing narratives
and group ethics at various levels of soci-
ety, especially among the socio-geneti-
cally marginal. Mediation of new social
and ethical views, argues Tsai, is an
important way of coping with the bias-
es and stereotypes generated through
the use of genetic technologies. 
Some reactions to this proposal were
sceptical. One member of the audience
wondered, who then, are those organic
intellectuals, and how could they
acquire the power to steer processes
that are so obviously part of an unfair
